Creo Medical Group PLC (CREO) — Net Asset Quality Index
Creo Medical Group PLC (CREO) has a Net Asset Quality Index of 84.6% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX59.10 Million minus total liabilities of GBX9.10 Million yields net assets of GBX50.00 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Creo Medical Group PLC defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Creo Medical Group PLC Net Asset Quality Index Over Time (2005–2025)
This chart shows how Creo Medical Group PLC's Net Asset Quality Index has evolved across 18 annual periods from 2005 to 2025. As of December 2025, the index stands at 84.6%, representing net assets of GBX50.00 Million against total assets of GBX59.10 Million GBX. Explore Creo Medical Group PLC (CREO) cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Creo Medical Group PLC (2005–2025)
The table below presents the year-by-year Net Asset Quality Index for Creo Medical Group PLC from 2005 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CREO market cap.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 84.6% | GBX50.00 Million | GBX59.10 Million | GBX9.10 Million | ▲ +19.4 pp |
| 2024 | 65.2% | GBX42.40 Million | GBX65.00 Million | GBX22.60 Million | ▼ -12.8 pp |
| 2023 | 78.1% | GBX59.80 Million | GBX76.60 Million | GBX16.80 Million | ▲ +12.5 pp |
| 2022 | 65.6% | GBX49.40 Million | GBX75.34 Million | GBX25.93 Million | ▼ -7.3 pp |
| 2021 | 72.9% | GBX73.32 Million | GBX100.61 Million | GBX27.29 Million | ▲ +4.9 pp |
| 2020 | 67.9% | GBX62.81 Million | GBX92.46 Million | GBX29.66 Million | ▼ -25.7 pp |
| 2019 | 93.7% | GBX82.66 Million | GBX88.26 Million | GBX5.60 Million | ▼ -2.3 pp |
| 2018 | 95.9% | GBX47.71 Million | GBX49.75 Million | GBX2.03 Million | ▲ +19.7 pp |
| 2018 | 76.2% | GBX7.33 Million | GBX9.62 Million | GBX2.29 Million | ▼ -14.7 pp |
| 2017 | 90.9% | GBX14.65 Million | GBX16.12 Million | GBX1.47 Million | ▲ +23.5 pp |
| 2016 | 67.4% | GBX1.63 Million | GBX2.42 Million | GBX788.81K | ▼ -18.4 pp |
| 2016 | 85.8% | GBX3.22 Million | GBX3.75 Million | GBX532.79K | ▲ +14.2 pp |
| 2015 | 71.7% | GBX748.41K | GBX1.04 Million | GBX295.98K | ▼ -12.9 pp |
| 2014 | 84.6% | GBX1.37 Million | GBX1.62 Million | GBX250.20K | ▲ +18.5 pp |
| 2008 | 66.1% | GBX113.00K | GBX171.00K | GBX58.00K | ▲ +61.4 pp |
| 2007 | 4.7% | GBX12.00K | GBX257.00K | GBX245.00K | ▲ +6.5 pp |
| 2006 | -1.9% | GBX-3.00K | GBX161.00K | GBX164.00K | ▲ +238.1 pp |
| 2005 | -240.0% | GBX-12.00K | GBX5.00K | GBX17.00K | — |